Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification

被引:449
作者
Savaria Morris, Martha [1 ]
Jacques, Paul F. [1 ]
Rosenberg, Irwin H. [1 ]
Selhub, Jacob [1 ]
机构
[1] Tufts Univ, Jean Mayer USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA
关键词
aging; anemia; cognition disorders; folate; fortified food; nutrition surveys; vitamin B-12 deficiency;
D O I
10.1093/ajcn/85.1.193
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Historic reports on the treatment of pernicious anemia with folic acid suggest that high-level folic acid fortification delays the diagnosis of or exacerbates the effects of vitamin B-12 deficiency, which affects many seniors. This idea is controversial, however, because observational data are few and inconclusive. Furthermore, experimental investigation is unethical. Objective: We examined the relations between serum folate and vitamin B-12 status relative to anemia, macrocytosis, and cognitive impairment (ie, Digit Symbol-Coding score < 34) in senior participants in the 1999-2002 US National Health and Nutrition Examination Survey. Design: The subjects had normal serum creatinine concentrations and reported no history of stroke, alcoholism, recent anemia therapy, or diseases of the liver, thyroid, or coronary arteries (n = 1459). We defined low vitamin B-12 status as a serum vitamin B-12 concentration < 148 pmol/L or a serum methylmalonic acid concentration > 210 nmol/L-the maximum of the reference range for serum vitamin B-12-replete participants with normal creatinine. Results: After control for demographic characteristics, cancer, smoking, alcohol intake, serum ferritin, and serum creatinine, low versus normal vitamin B-12 status was associated with anemia [odds ratio (OR): 2.7; 95% Cl: 1.7,4.2), macrocytosis (OR: 1.8; 95% Cl: 1.01, 3.3), and cognitive impairment (OR: 2.5; 95% Cl: 1.6, 3.8). In the group with a low vitamin B-12 status, serum folate > 59 nmol/L (80th percentile), as opposed to <= 59 nmol/L, was associated with anemia (OR: 3.1; 95% Cl: 1.5, 6.6) and cognitive impairment (OR: 2.6; 95% Cl: 1.1, 6.1). In the normal vitamin B-12 group, ORs relating high versus normal serum folate to these outcomes were < 1.0 (P-interaction < 0.05), but significantly < 1.0 only for cognitive impairment (0.4; 95% Cl: 0.2, 0.9). Conclusion: In seniors with low vitamin B-12 status, high serum folate was associated with anemia and cognitive impairment. When vitamin B-12 status was normal, however, high serum folate was associated with protection against cognitive impairment.
引用
收藏
页码:193 / 200
页数:8
相关论文
共 82 条
[11]   Subtle cobalamin deficiency [J].
Carmel, R .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (03) :338-340
[12]  
Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62
[13]   Folic acid intake from fortification in United States exceeds predictions [J].
Choumenkovitch, SF ;
Selhub, J ;
Wilson, PWF ;
Rader, JI ;
Rosenberg, IH ;
Jacques, PF .
JOURNAL OF NUTRITION, 2002, 132 (09) :2792-2798
[14]   Folic acid fortification increases red blood cell folate concentrations in the Framingham Study [J].
Choumenkovitch, SF ;
Jacques, PF ;
Nadeau, MR ;
Wilson, PWF ;
Rosenberg, IH ;
Selhub, J .
JOURNAL OF NUTRITION, 2001, 131 (12) :3277-3280
[15]   Screening for vitamin B-12 and folate deficiency in older persons [J].
Clarke, R ;
Refsum, H ;
Birks, J ;
Evans, JG ;
Johnston, C ;
Sherliker, P ;
Ueland, PM ;
Schneede, J ;
McPartlin, J ;
Nexo, E ;
Scott, JM .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2003, 77 (05) :1241-1247
[16]  
Corrada Maria M, 2005, Alzheimers Dement, V1, P11, DOI 10.1016/j.jalz.2005.06.001
[17]   Folate and brain function in the elderly [J].
D'Anci, KE ;
Rosenberg, IH .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2004, 7 (06) :659-664
[18]   Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation [J].
Dhar, M ;
Bellevue, R ;
Carmel, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) :2204-2207
[19]  
DICKINSON CJ, 1995, BRIT MED J, V311, P949
[20]  
DICKINSON CJ, 1995, QJM-INT J MED, V88, P357